穂積康夫 (Yasuo Hozumi) - 論文

Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study

Mukai, Hirofumi, Yamaguchi, Takeshi, Takahashi, Masato, Hozumi, Yasuo, Fujisawa, Tomomi, Ohsumi, Shozo, Akabane, Hiromitsu, Nishimura, Reiki, Takashima, Tsutomu, Park, Youngjin, Sagara, Yasuaki, Toyama, Tatsuya, Imoto, Shigeru, Mizuno, Toshiro, Yamashita, Satoshi, Fujii, Satoshi, Uemura, Yukari

British journal of cancer 2020年4月査読有り

Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer

Matsunuma, Ryoichi, Watanabe, Toru, Hozumi, Yasuo, Koizumi, Kei, Ito, Yasushi, Maruyama, Shoko, Ogura, Hiroyuki, Goto, Keigo, Mori, Hiroki, Sawai, Noriko, Shiiya, Norihiko

Breast cancer (Tokyo, Japan) 2020 2020年3月査読有り

Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study

Ohno, Shinji, Mukai, Hirofumi, Narui, Kazutaka, Hozumi, Yasuo, Miyoshi, Yasuo, Yoshino, Hiroshi, Doihara, Hiroyoshi, Suto, Akihiko, Tamura, Motoshi, Morimoto, Takashi, Zaha, Hisamitsu, Chishima, Takashi, Nishimura, Reiki, Ishikawa, Takashi, Uemura, Yukari, Ohashi, Yasuo

BREAST CANCER RESEARCH AND TREATMENT 176(3) 631 - 635 2019年8月査読有り

HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer

Kitahara, Miyuki, Hozumi, Yasuo, Nakamura, Ayaka, Tachi, Kana, Saitoh, Hitoaki, Iijima, Tatsuo

Case reports in oncology 12(2) 473 - 479 2019年6月査読有り

HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer

Kitahara, Miyuki, Hozumi, Yasuo, Nakamura, Ayaka, Tachi, Kana, Saitoh, Hitoaki, Iijima, Tatsuo

Case reports in oncology 12(2) 473 - 479 2019年6月査読有り

Evaluation of oral S-1 as a first-line chemotherapy for metastatic HER2-negative breast cancer: An analysis of two randomized phase III studies (SELECT BC-CONFIRM and SELECT BC)

Nishimura, Reiki, Mukai, Hirofumi, Uemura, Yukari, Akabane, Hiromitsu, Park, Youngjin, Takahashi, Masato, Sagara, Yoshiaki, Takashima, Tsutomu, Fujisawa, Tomomi, Hozumi, Yasuo, Kawahara, Takuya, Watanabe, Takanori

JOURNAL OF CLINICAL ONCOLOGY 37(15::S) 2019年5月

A prospective randomized multi-center open-label phase III trial of extending aromatase-inhibitor adjuvant therapy to 10 years - Results from 1697 postmenopausal women in the N-SAS BC 05 trial: Arimidex extended adjuvant randomized study (AERAS)

Ohtani, S, Iijima, K, Higaki, K, Sato, Y, Hozumi, Y, Hasegawa, Y, Takei, H, Tanaka, M, Yagata, H, Masuoka, H, Tanabe, M, Egawa, C, Komoike, Y, Saji, S, Nakamura, T, Yanagita, Y, Ohtsu, H, Mukai, H, Iwase, T

CANCER RESEARCH 79(4::S) 2019年2月査読有り

Randomized phase 3 study of anthracycline-containing regimens versus S-1 as first-line treatment for metastatic breast cancer (SELECT BC-CONFIRM)-A combined analysis of two randomized phase 3 studies (SELECT BC-CONFIRM and SELECT BC)-

Park, Y, Akabane, H, Watanabe, T, Takahashi, M, Sagara, Y, Nishimura, R, Tsurutani, J, Takashima, T, Fujisawa, T, Hozumi, Y, Uemura, Y, Mukai, H

CANCER RESEARCH 79(4::S) 2019年2月

Bowen's Disease of the Nipple

Kitahara, Miyuki, Hozumi, Yasuo, Watanabe, Akie, Iijima, Tatsuo

Case reports in oncology 11(3) 609 - 614 2018年9月査読有り

Intramammary Metastasis in a Patient with a History of Renal Cell Carcinoma: A Case Report

Kitahara, Miyuki, Hozumi, Yasuo, Asada, Rio, Sawa, Aya, Saito, Hitoaki, Iijima, Tatsuo

Case reports in oncology 11(2) 318 - 322 2018年5月査読有り

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

Takeru Shiroiwa, Takashi Fukuda, Kojiro Shimozuma, Mitsuko Mouri, Yasuhiro Hagiwara, Takuya Kawahara, Shozo Ohsumi, Yasuo Hozumi, Yoshiaki Sagara, Yasuo Ohashi, Hirofumi Mukai

BMC CANCER 17(1) 773 2017年11月査読有り

乳癌術前化学療法後の病理学的完全奏功予測の評価

寺崎梓, Bando, Hiroko, 高木理央, 星葵, 橋本幸枝, 田地佳那, 市岡恵美香, 都島由希子, 池田達彦, 井口研子, 穂積康夫, 原尚人

第25回日本乳癌学会学術総会プログラム・抄録集 2017年7月査読有り

原発性肝癌との鑑別を要し治療方針決定に肝生検が有用であった乳癌術後肝転移の1例－乳癌術後転移疑病変に対する生検時に考慮すべき事項－

北原美由紀, Hozumi, Yasuo, 松尾知平, 塩澤幹雄, 斉藤仁昭, 飯島達生, 高尾幹也, 阿部秀樹

乳癌の臨床 157 - 165 2017年4月査読有り

Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylation

Satoshi Fujii, Satoshi Yamashita, Takeshi Yamaguchi, Masato Takahashi, Yasuo Hozumi, Toshikazu Ushijima, Hirofumi Mukai

ONCOTARGET 8(12) 19039 - 19048 2017年3月査読有り

Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer

Hideyuki Ohzawa, Atsushi Miki, Takumi Teratani, Satomi Shiba, Yasunaru Sakuma, Wataru Nishimura, Yasuko Noda, Noriyoshi Fukushima, Hirofumi Fujii, Yasuo Hozumi, Hirofumi Mukai, Yoshikazu Yasuda

ONCOLOGY LETTERS 13(3) 1731 - 1740 2017年3月査読有り

高齢者乳癌患者に対する外科的治療の検討

松尾, 知平, 北原, 美由紀, 穂積, 康夫, Bando, Hiroko, 原, 尚人

日本外科学会雑誌 118(増刊(2)) 2017年2月査読有り

腋窩リンパ節腫大を認めた良性乳腺顆粒細胞腫の1症例

田中, 裕美子, 藤田崇史, 芝聡美, 西田紗季, 宮崎千絵子, 櫻木雅子, 森田剛平, 仁木利郎, 尾本きよか, 軽部真粧美, Hozumi, Yasuo, アラン K.・レフォー, 佐田尚宏

乳癌の臨床 32(1) 59 - 65 2017年2月査読有り

Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors

Hirofumi Mukai, Ken Kato, Taito Esaki, Shouzou Ohsumi, Yasuo Hozomi, Nobuaki Matsubara, Tetsuya Hamaguchi, Yasuhiro Matsumura, Rika Goda, Takayuki Hirai, Yoshihiro Nambu

INVESTIGATIONAL NEW DRUGS 34(6) 750 - 759 2016年12月査読有り

COST-EFFECTIVENESS OF FIRST-LINE S-1 THERAPY FOR METASTATIC BREAST CANCER PATIENTS COMPARED WITH TAXANES: AN ANALYSIS BASED ON THE RANDOMIZED PHASE III SELECT BC TRIAL

Shiroiwa, T, Fukuda, T, Shimozuma, K, Mouri, M, Hagiwara, Y, Kawahara, T, Ohsumi, S, Hozumi, Y, Sagara, Y, Ohashi, Y, Mukai, H

VALUE IN HEALTH 19(7) A737 - A737 2016年11月

癌に対するプレシジョンメディシン Ki-67 indexを用いたHER2陽性乳癌に対する治療選択研究

向井, 博文, 山口, 雄, 高橋, 將人, Hozumi, Yasuo, 藤澤知巳, 大住省三, 赤羽弘充, 西村令喜, 高島勉, 朴英進, 相良安昭, 遠山竜也, 井本滋, 水野聡朗, 上村夕香理

日本癌治療学会学術集会抄録集 54回 2016年10月